Skip to Content

Get Your FREE Consultation

Blog

Concerns Raised Over Banks Entering Short-Term Loan Market

November 7, 2012

Concerns have been raised about large banks beginning to make short-term loans similar to those found in the oft-criticized and problem-plagued payday lending arena. Banks have faced lower revenue as a result of limits on debit card and overdraft fees. Those lenders are now offering high-cost loans that are meant […]

Learn More

CFPB To Begin Oversight of Debit Collectors

November 6, 2012

Debt collection agencies will come under federal review for the first time beginning January 2, 2013, when the Consumer Financial Protection Bureau (CFPB) begins oversight. The agency’s authority to oversee debt collection agencies comes under the portion of the Dodd-Frank regulatory law that deals with nonbank financial companies. CFPB will […]

Learn More

FTC Obtains Settlement in Phony Debt Collection Case

November 5, 2012

The Federal Trade Commission (FTC) reached a settlement with defendants in the United States who abetted unlawful debt collection calls from India. A California man who worked with bogus debt collectors in India has agreed to settle FTC charges that he and his companies deceived and threatened consumers into paying […]

Learn More

Regular Checks of Credit Reports Will Help Consumers’ Creditworthiness Ratings

October 31, 2012

In recent studies, it has been reported that the credit reports on which lenders rely in making decisions about consumers’ credit worthiness often contain errors. The end result can be increased borrowing costs for consumers. Past studies of the accuracy of credit reports found that between 30 percent and 80 […]

Learn More

Boehringer Ingelheim Settles False Claims Act Case for $95 Million

October 31, 2012

Boehringer Ingelheim Pharmaceuticals, Inc. has agreed to pay $95 million to settle a False Claims Act case in which it was alleged that the drug company improperly marketed drugs and caused false claims to be submitted to government healthcare programs. The drugs at issue are Aggrenox, a medication used to […]

Learn More

CFPB Now Accepting Credit Reporting Complaints

October 30, 2012

The Consumer Financial Protection Bureau (CFPB) announced that it is accepting consumer complaints about credit reporting, providing consumers individual-level complaint assistance for the first time at the federal level. To file a credit reporting complaint, consumers can file online at www.consumerfinance.gov/complaint. Consumers can also lodge a complaint by phone at […]

Learn More

Fiscal Year 2012 A Record Year for False Claims Act Recoveries

October 29, 2012

Fiscal Year 2012 saw more than $9 billion returned to the government through federal and state False Claims Act cases. Of the 30 largest recoveries in Fiscal Year 2012, 28 were the result of whistleblower-initiated suits. The largest settlement was for $3 billion, with GlaxoSmithKline over illegal marketing of nine […]

Learn More

CVS Subsidiary Settles False Pricing Allegations Related to Medicare

October 26, 2012

In one of the first False Claims Act settlements involving Medicare Part D, the Medicare prescription drug program, RxAmerica LLC has agreed to settle fraud claims with the Department of Justice for $5.25 million. RxAmerica is a wholly-owned subsidiary of CVS Caremark Corporation and provides prescription drug benefits to Medicare […]

Learn More

CFPB Investigates Reverse Mortgage Market

October 25, 2012

The Consumer Financial Protection Bureau (CFPB) is considering issuing rules aimed at preventing abuses in the reverse mortgage market. The agency is responding to an increasing number of claims by consumers who report losing their homes or facing substantial expense as a result of reverse mortgage scams. Complaints have escalated […]

Learn More

NC Receives $15.8 Million From Abbott Labs Whistleblower Settlement

October 24, 2012

In conjunction with a national healthcare fraud settlement with Abbott Labs, North Carolina has recovered $15.8 million. That is the state’s portion of the recently announced $800 million settlement between Abbott Labs and the federal government and states involving the drug Depakote. That drug was approved by the FDA to […]

Learn More
TALK TO US NOW
FOR FREE
No Win, No Fee

Review Us

Martin & Jones, PLLC logo

“Forest, once again, my family and I thank you for obtaining another settlement on behalf of my Father. It’s almost uncanny that these checks seem to come at very opportune times. This one comes as we are expecting our fourth grandchild. It will provide her some sound footing towards her future college education, plus help Mom and Dad with the medical expenses. Sometimes, I think my Dad is helping you guys with this. Maybe so. Anyway, thank you again for your hard work.”

Contact Our North Carolina Personal Injury Law Firm

for a Consultation for Your Accident or Medical Malpractice Claim

Call us at 800-662-1234
TALK TO US NOW
FOR FREE
No Win, No Fee

The law firm you choose makes a difference. If you are the victim of an accident or an illness that someone else caused, the North Carolina personal injury law firm of Martin & Jones has the depth of experience, skills and sensitivity to make your road to recovery as smooth as possible. Whether you have experience with the legal system or have never hired a medical malpractice or personal injury lawyer before, our attorneys and staff will do our best to answer your questions, provide clear advice and prepare you and your family for what to expect. If you would like more information or to meet with one of our attorneys, please fill out the form below or call us at 800.662.1234.